Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
Pharmacoepidemiol Drug Saf
; 10(4): 295-300, 2001.
Article
in En
| MEDLINE
| ID: mdl-11760489
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drugs, Generic
/
Insurance, Pharmaceutical Services
/
National Health Programs
Type of study:
Etiology_studies
/
Health_economic_evaluation
/
Incidence_studies
/
Observational_studies
Limits:
Humans
Country/Region as subject:
Oceania
Language:
En
Journal:
Pharmacoepidemiol Drug Saf
Journal subject:
EPIDEMIOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2001
Document type:
Article
Affiliation country:
Australia